http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102250127-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6077d9bd8b6ee0093203fdc84b99bd6c
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
filingDate 2010-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bbb99de4fd0cfedf53cbf0bc73b8f82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdfbca2316372b1eca3512e862337e1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5a2fd8017dd59db80a1e8a46fe20b3a
publicationDate 2011-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102250127-A
titleOfInvention Tetrahydrocarboline derivatives modified by two amino acids and their preparation methods and applications
abstract The invention discloses two amino acid modified tetrahydrocarboline derivatives, a preparation method and application thereof. In the present invention, a series of (1R,3S)-1-[ 1-(1R, 3S)-tetrahydro β-carboline-3-formyl amino acid-1-yl-methyl]-tetrahydro β-carboline-3-formyl amino acid derivatives and their intermediates, and to These derivatives were evaluated for in vitro antiplatelet aggregation activity and in vivo antithrombotic activity. The method of the invention is simple, the raw materials used are easy to obtain, safe and cheap, and the obtained product has anti-platelet aggregation activity and antithrombotic activity, which indicates that (1R, 3S)-1-[1-(1R, 3S)-tetrahydroβ-carba The clinical application prospect of pheno-3-carboline-3-formyl amino acid as an antithrombotic agent.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103159758-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103450067-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103450067-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103159758-B
priorityDate 2010-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005089764-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101497611-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466136518
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56959318
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465874085

Total number of triples: 26.